Our Firm is representing numerous women who have filed Mirena IUD lawsuits in this proceeding. We are pleased to see the litigation moving forward.
New York, New York (PRWEB) May 30, 2014
Hundreds of Mirena IUD lawsuits (http://www.injurybeacon.com/mirena-iud/lawsuit/) filed on behalf of women who were allegedly injured due to spontaneous migration of the birth control device continue to move forward in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Case Management Order issued on May 21, 2014, the Court has established protocols governing the selection of Mirena lawsuits for inclusion in the litigation’s Initial Deposition Pool. Among other things, the Order directs each side to choose eight cases for inclusion in the pool, and provide the Court with notice of those selections by June 3, 2014. (In Re: Mirena Litigation; Case No. 297)
“Our Firm is representing numerous women who have filed Mirena IUD lawsuits in this proceeding. We are pleased to see the litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who allegedly suffered serious Mirena side effects caused by spontaneous migration of their IUD.
Mirena Lawsuit Allegations
According to court documents, at least 811 claims have been filed in Bergen County Superior Court on behalf of women who allegedly experienced spontaneous migration of their IUD, as well as related Mirena side effects, including uterine perforations, ectopic pregnancy, scarring and infertility. Among other things, plaintiffs claim that the labeling for the IUD fails to note that the device can spontaneously migrate from its proper position in the uterus, even after being correctly inserted by a doctor. Instead, the label only warns that migration may occur if the uterus is perforated upon insertion.
In addition to the claims pending in Bergen County Superior Court, more than 500 Mirena lawsuits have been filed in a federal multidistrict litigation underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
According to a report that was broadcast by 7 Action News last August, the U.S. Food & Drug Administration (FDA) has logged more than 70,000 complaints involving device dislocation, uterine perforation and other Mirena side effects since the IUD was launched on the U.S. market in 2000.* In 2009, Bayer Healthcare Pharmaceuticals was cited by the FDA for a marketing campaign that the agency said exaggerated the IUD’s benefits and downplayed the risk of serious Mirena side effects.
Women who suffered uterine perforations, infertility, and other Mirena side effects allegedly associated with spontaneous device migration may be eligible to file their own Mirena IUD lawsuit. To learn more about the risks allegedly linked to Mirena, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential evaluation of a potential Mirena lawsuit, please call 800-511-5092.
*wxyz.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-dangerous-complications-from-mirena-iud-birth-control, 7 Action News, August 27, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com